'Adjuvant chemotherapy' presentation slideshows

Breast Cancer Highlights From San Antonio

1.23k views • 95 slides

Breast Cancer Patient Issues in Family Practice: An Interactive Session

Breast Cancer Patient Issues in Family Practice: An Interactive Session. Acknowledgements. Content Development Committee Sunil Verma, MD, MSEd, FRCPC Lisa Del Giudice, MSc, MD, CCFP Medical Oncologist, Staff Division of Medical Department of Family Medicine

1.18k views • 89 slides

Treatment

Treatment. Goal: The ultimate goal is a cure: long-term, disease-free survival If not attainable control of the disease (stop the cancer from enlarging and spreading) to extend survival maintain the best quality of life.

882 views • 73 slides

Chemotherapy

Chemotherapy. Chemotherapy. History General approaches Preparation Commonly used agents mechanism of action indications toxicity. Ancient practices. Medieval times. 19 th Century. 20 th Century. Different approaches to using chemotherapy. Combination chemotherapy

1.1k views • 68 slides

Neoadjuvant and Adjuvant Chemotherapy for Liver Limited Metastases from Colorectal Cancer

Neoadjuvant and Adjuvant Chemotherapy for Liver Limited Metastases from Colorectal Cancer. Heinz-Josef Lenz , MD FACP Professor of Medici ne USC Norris Comprehensive Cancer Center. Questions. When to treat with chemotherapy What is the right chemotherapy prior surgery

1.16k views • 49 slides

Adjuvant Breast Cancer Therapy An Analysis of Current Treatment Paradigms

Adjuvant Breast Cancer Therapy An Analysis of Current Treatment Paradigms. Mark D. Pegram, MD UCLA/Jonsson Comprehensive Cancer Center. Age 47 Premenopausal breast carcinoma Lumpectomy - 1.3 cm poorly differentiated, high grade infiltrating ductal carcinoma

828 views • 41 slides

NON METASTATIC OSTEOSARCOMA. EXPERIENCE AT SKMCH & RC

NON METASTATIC OSTEOSARCOMA. EXPERIENCE AT SKMCH & RC . ALIA ZAIDI, AHSAN SHAMIM, WASILA SHAMIM SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE. SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE, LAHORE, PAKISTAN.

562 views • 39 slides

Adjuvant therapy in stage III colorectal cancer; Is less, better?

Adjuvant therapy in stage III colorectal cancer; Is less, better?. Ioannis P. Boukovinas MD, PhD , PharmaD Medical Oncologist Bioclinic Thessaloniki ibouk@otenet.gr. Conflict of interest. Nothing to declare concerning this talk.

572 views • 34 slides

NCT00688740 Sponsored by sanofi-aventis

Ten-year follow-up analysis of the BCIRG 001 trial confirms superior DFS and OS benefit of adjuvant TAC ( docetaxel , doxorubicin, cyclophosphamide ) over FAC (fluorouracil, doxorubicin, cyclophosphamide ) in women with operable node-positive breast cancer.

431 views • 26 slides

Eshuis , van der Gaag , Rauws et al November 2010 Annals of Surgery;252(5):840-849

Therapeutic Delay and Survival after Surgery for Cancer of the Pancreatic Head with or without Preoperative Biliary Drainage. Eshuis , van der Gaag , Rauws et al November 2010 Annals of Surgery;252(5):840-849 Journal Club 15 th November 2010. Background.

501 views • 25 slides

494 views • 25 slides

Yoon-Koo Kang, Heung-Moon Chang, Dae Young Zang,

443 views • 25 slides

Pharmacology of Antineoplastic Agents

Pharmacology of Antineoplastic Agents. Outline of Lecture Topics:. Background Antineoplastic Agents a. Cell Cycle Specific (CCS) b. Cell Cycle Non-Specific (CCNS) c. Miscellaneous (e.g., antibodies) Mechanisms of action Side Effects Drug Resistance. Cancer Therapeutic Modalities.

947 views • 24 slides

Combination regimens for adjuvant therapy of stage III colon cancer: the next level of therapy

603 views • 23 slides

Monalisa SUR Cases: 8 th February AIPNA CME Presentation

Monalisa SUR Cases: 8 th February AIPNA CME Presentation.

219 views • 14 slides

NSCLC stage IIIA type of chemotherapy ?

322 views • 11 slides

CLINICAL PRACTICE GUIDELINES

CLINICAL PRACTICE GUIDELINES. Vivien Bramwell Chair, NCIC-CTG Sarcoma Committee Canadian Sarcoma Group. Connective Tissue Oncology Society 2005 Meeting, Boca Raton. CTOS 2005 - CPG. Canada Health Act Federal mandate Provincial delivery of services.

285 views • 10 slides

Authors: DJ Sargent et al Date posted: June 26 2008

Deficient Mismatch Repair as a Predictive Marker for Lack of Benefit from 5-FU based Chemotherapy in Adjuvant Colon Cancer. Authors: DJ Sargent et al Date posted: June 26 2008. Background/Rationale.

193 views • 6 slides

Adjuvant chemotherapy in older women with breast cancer (AChEW): identifying perceptions

Adjuvant chemotherapy in older women with breast cancer (AChEW): identifying perceptions and putative barriers in decision-making Lesley Fallowfield 1 , Helena Harder 1 , Carolyn Langridge 1 , Rachel Ballinger 1 , Alistair Ring 2

108 views • 1 slides

Supplementary Fig S11

Disease-free survival ( p =0.02). Overall survival ( p =0.011). Supplementary Fig. S11. Kaplan-Meir analysis comparing patients with chemosensitive with chemoresistant tumors for overall survival and disease free survival

121 views • 1 slides